Disclosures for "Feasibility of a Home-Based Exergame Therapy for Youth with Spinal Muscular Atrophy")
-
Dr. Oskoui has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for the Association des Neurologues du Quebec. The institution of Dr. Oskoui has received research support from Biogen. The institution of Dr. Oskoui has received research support from Roche Genetech. The institution of Dr. Oskoui has received research support from Muscular Dystrophy Canada. The institution of Dr. Oskoui has received research support from Canadian Institutes of Health Research. Dr. Oskoui has received personal compensation in the range of $50,000-$99,999 for serving as a Methodologist with American Academy of Neurology. Dr. Oskoui has a non-compensated relationship as a Member of the Medical and Scientific Advisory Committee with Muscular Dystrophy Canada that is relevant to AAN interests or activities.
-
The institution of Dr. Selby has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Selby has received research support from Biogen . The institution of Dr. Selby has received research support from Italfarmico. The institution of Dr. Selby has received research support from Reverogen.
-
Mr. Herzig has received personal compensation for serving as an employee of F. Hoffmann - La Roche AG. Mr. Herzig has stock in F. Hoffmann - La Roche AG. Mr. Herzig has received personal compensation in the range of $5,000-$9,999 for serving as a Lecturer with FHNW.
-
Mrs. Cardiff has nothing to disclose.
-
Miss Cushen has nothing to disclose.
-
Mr. Défossés has nothing to disclose.
-
Dr. Gonorazky has received personal compensation for serving as an employee of Novartis. Dr. Gonorazky has received personal compensation for serving as an employee of Biogen. Dr. Gonorazky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
-
Dr. Gottowik has received personal compensation for serving as an employee of F. Hoffmann–La Roche Ltd.
-
Renee Haldenby has received personal compensation for serving as an employee of Hoffmann-LaRoche Ltd.
-
Mr. Jurisic has received personal compensation for serving as an employee of Roche.
-
Miss Karthigesu has nothing to disclose.
-
Ms. Macintyre has nothing to disclose.
-
The institution of Alex MacKenzie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen.
-
Dr. Mah has nothing to disclose.
-
Mr. McCullough has received personal compensation for serving as an employee of Hoffmann-La Roche Limited. Mr. McCullough has stock in Roche Holding AG.
-
Ms. Ng has received personal compensation for serving as an employee of Research Institute of the McGill University Health Centre.
-
Ms. Opalka has received personal compensation for serving as an employee of Transition Technologies PSC . Ms. Opalka has received personal compensation for serving as an employee of Technical University of Lodz. Ms. Opalka has received personal compensation in the range of $500-$4,999 for serving as a Academic teacher with Technical University of Lodz. Ms. Opalka has received personal compensation in the range of $10,000-$49,999 for serving as a PhD candidate with Technical University of Lodz.
-
Mr. Openchowski has received personal compensation for serving as an employee of Roche. Mr. Openchowski has stock in Roche.
-
Svetlana Petkun has received personal compensation for serving as an employee of Hoffmann-La Roche Inc..
-
The institution of Dr. Potter has received research support from Cambrooke Ajimoto. The institution of Dr. Potter has received research support from Nutricia. The institution of Dr. Potter has received research support from Biomarin.
-
The institution of Dr. Sheriko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Sheriko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Sheriko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. The institution of Dr. Sheriko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Sheriko has received research support from MARS VR Labs. The institution of Dr. Sheriko has received research support from CIHR. The institution of Dr. Sheriko has received research support from IWK Health.
-
Ms. Smith has nothing to disclose.
-
Dr. Strahm has received personal compensation for serving as an employee of F. Hoffmann-La Roche.
-
Ms. Turgeon Desilets has nothing to disclose.
-
Ms. Woof has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ATOM. Ms. Woof has received personal compensation in the range of $50,000-$99,999 for serving as a Leader of Physiotherapy with BC Centre for Ability.
-
Dr. Chen has nothing to disclose.